Murphy Canyon Acquisition Corp. (NASDAQ:MURF) announced this afternoon that its special meeting, scheduled for September 13, has been postponed to September 20 at 10:00 a.m., marking the SPAC’s second postponement.
As a result of this change, Murphy Canyon has also extended the redemption deadline for holders of its common stock to 5:00 p.m. ET, on September 18.
At the meeting, MURF stockholders will be asked to vote on a proposal to approve its $700.5 million business combination with drug developer Conduit Pharmaceuticals.
Murphy Canyon inked the deal with Conduit in November 2022. The SPAC originally brought $136 million into the deal from its trust, but saw 83.46% of this redeemed during a January extension meeting, leaving it with $22.6 million post-vote. It has supplemented this with a $27 million PIPE at $10 per share including both new and existing investors.
London-based Conduit is working to develop a range of treatments licensed from AstraZeneca (NASDAQ:AZN) with the aim of exiting these assets following the completion of Phase II trials.
The combined company is expected to trade on the Nasdaq under the symbol “CDT” once the deal is completed.
Globa Terra Acquisition Corporation (NASDAQ:GTERU) announced the pricing of its $152 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “GTERU”, Wednesday, July 9, 2025. The new SPAC plans to mount a search for a target in the agriculture, agtech or biotech sectors with an emphasis on water...
M3-Brigade V (NASDAQ:MBAV) has entered into a definitive agreement to combine with crypto treasury firm ReserveOne, assembling about $1 billion in equity funding. ReserveOne is setting up a diversified Bitcoin and digital asset treasury with a portion of its investments going towards blockchain infrastructure and venture raises. The combined company is expected to trade on...
At the SPAC of Dawn As the SPAC market has warmed in 2025, only 21 of the 70 SPACs (30%) that have IPO’d thus far have overfunded their trusts to draw in investors and none of these funded to more than 101%. By contrast, 87% of 2023 SPACs were overfunded – some to as high...
Emmis Acquisition Corporation (NASDAQ:EMISU) has filed for a $100 million SPAC to take a look at the manufacturing sector after a few unique wrinkles in their IPO process. Initial investors are set to receive one right to a 1/10 share in each unit purchased and the SPAC will have 18 months to complete a business...
Chenghe III (NASDAQ:CHEC.U) has filed for a $110 million SPAC to continue the team’s growing series while turning to a new underwriter. The new SPAC is offering investors a 1/2 warrant in each unit and no overfunding of the trust, but it will need to complete a business combination within 18 months of its IPO...